Prognostic Score Including Gene Mutations in Chronic Myelomonocytic LeukemiaRaphaël Itzykson, Éric Solary, Olivier Bernard et al.|Journal of Clinical Oncology|2013Cited by 543
Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With<i>NPM1</i>Mutation: A Study by the Acute Leukemia French Association GroupMarie Balsat, Nicolas Boissel, Aline Renneville et al.|Journal of Clinical Oncology|2017Cited by 292
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trialThorsten Braun|Blood|2011Cited by 198
<i>UBA1</i> Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS SyndromeÈve Zakine, Jean‐David Bouaziz, Bérénice Schell et al.|JAMA Dermatology|2021Cited by 120
Significance of Measurable Residual Disease in Adult Philadelphia Chromosome–Positive ALL: A GRAAPH-2014 StudyRathana Kim, Emmanuelle Clappier, Yves Chalandon et al.|Journal of Clinical Oncology|2024Cited by 39